Methods of nucleic acid sample preparation
Inventors
Stahl, Joshua • Myers, Jason • Culver, Brady • Kudlow, Brian
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
Aspects of the technology disclosed herein relate to methods of preparing and analyzing nucleic acids. In some embodiments, methods for preparing nucleic acids for sequence analysis (e.g., using next-generation sequencing) are provided herein.
Core Innovation
The invention relates to methods of preparing nucleic acids for analysis using a capture moiety modified nucleotide associated with an adapter-based ligation workflow. A double-stranded nucleic acid comprising a target nucleotide sequence receives one or more nucleotides at a 3′ end, where at least one nucleotide is a capture moiety modified nucleotide, and an adapter nucleic acid is ligated to at least one strand to produce a ligation product comprising the capture moiety modified nucleotides.
The prepared ligation product is captured by contacting it with a binding partner of the capture moiety modified nucleotide, thereby providing an immobilized ligation product in some embodiments. In certain embodiments, the ligation product is separated from the binding partner and amplified to provide amplicons, including amplification by a polymerase chain reaction using a first target-specific primer and a first adapter primer that specifically anneals to a complementary sequence of the adapter nucleic acid.
The method extends to preparing nucleic acids from a plurality of double-stranded nucleic acids comprising different target nucleotide sequences. The approach adds capture moiety modified nucleotides to 3′ ends of each double-stranded nucleic acid, ligates an adapter to generate a plurality of ligation products, captures the plurality of ligation products using the binding partner, and amplifies the plurality of ligation products to provide a plurality of amplicons.
Claims Coverage
The consolidated content identifies four independent claims. Across these claims, the inventive features center on 3′-end addition of capture moiety modified nucleotides, adapter ligation to form capture-modified ligation products, capture using a binding partner, and, in some claims, separation and amplification to provide amplicons, including parallel processing of multiple different target nucleotide sequences.
Capture moiety modified nucleotide addition at 3′ ends
Adding one or more nucleotides to a 3′ end of a double-stranded nucleic acid comprising a target nucleotide sequence, wherein at least one of the one or more nucleotides is a capture moiety modified nucleotide.
Adapter ligation to form a capture moiety ligation product
Ligating an adapter nucleic acid to at least one strand of the double-stranded nucleic acid to produce a ligation product comprising the one or more capture moiety modified nucleotides.
Capture by a binding partner of the capture moiety
Capturing the ligation product by contacting the ligation product with a binding partner of the capture moiety modified nucleotide.
Amplification after capture using target-specific and adapter primers
Optionally washing the immobilized ligation product, separating the ligation product from the binding partner, and amplifying the separated ligation product by a polymerase chain reaction using a first target-specific primer and a first adapter primer that specifically anneals to a complementary sequence of the adapter nucleic acid.
Parallel processing of multiple different target nucleotide sequences
Adding one or more nucleotides to a 3′ end of each of a plurality of double-stranded nucleic acids comprising a plurality of different target nucleotide sequences, ligating an adapter nucleic acid to each, capturing the plurality of ligation products, and amplifying the plurality of ligation products to provide a plurality of amplicons.
Enzymatic addition and ligase-mediated adapter attachment
Combining a double-stranded nucleic acid, a modified nucleotide comprising a capture moiety, and an enzyme under conditions in which the enzyme adds the modified nucleotide to a 3′ end of the double-stranded nucleic acid; combining the double-stranded nucleic acid, an adapter nucleic acid, and a ligase under conditions in which the ligase ligates the adapter nucleic acid to the double-stranded nucleic acid; and combining the ligation product and a binding partner of the capture moiety under conditions in which the binding partner forms a complex with the ligation product.
Across the independent claims, the coverage focuses on preparing nucleic acids for analysis by adding capture moiety modified nucleotides to 3′ ends of double-stranded nucleic acids, ligating adapters to create capture moiety-containing ligation products, capturing those products using a binding partner of the capture moiety, and, in certain claims, separating and amplifying to provide amplicons or directly amplifying after capture for multiple target nucleotide sequences.
Stated Advantages
Not explicitly described in patent.
Documented Applications
Not explicitly described in patent.
Interested in licensing this patent?